Associations between urinary caffeine and caffeine metabolites and cognitive function in older adults

References

• Collaborators GBDD. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2019;18(1):88–106.
   PubMed Web of Science ®Google Scholar
• 2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020.
   Google Scholar
• Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, et al. World-wide FINGERS network: a global approach to risk reduction and prevention of dementia. Alzheimers Dement. 2020;16(7):1078–94.
   PubMed Web of Science ®Google Scholar
• Flanagan E, Lamport D, Brennan L, Burnet P, Calabrese V, Cunnane SC, et al. Nutrition and the ageing brain: moving towards clinical applications. Ageing Res Rev. 2020;62:101079.
   PubMed Web of Science ®Google Scholar
• Dominguez LJ, Barbagallo M, Munoz-Garcia M, Godos J, Martinez-Gonzalez MA. Dietary patterns and cognitive decline: key features for prevention. Curr Pharm Des. 2019;25(22):2428–42.
   PubMed Web of Science ®Google Scholar
• Onatibia-Astibia A, Franco R, Martinez-Pinilla E. Health benefits of methylxanthines in neurodegenerative diseases. Mol Nutr Food Res. 2017;61(6):1600670.
   Web of Science ®Google Scholar
• Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Beverage caffeine intakes in the U.S. Food Chem Toxicol. 2014;63:136–42.
   PubMed Web of Science ®Google Scholar
• Kim JW, Byun MS, Yi D, Lee JH, Jeon SY, Jung G, et al. Coffee intake and decreased amyloid pathology in human brain. Transl Psychiatry. 2019;9(1):270.
   PubMed Web of Science ®Google Scholar
• Barbaresko J, Rienks J, Nothlings U. Lifestyle indices and cardiovascular disease risk: a meta-analysis. Am J Prev Med. 2018;55(4):555–64.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr. 2014;53(1):25–38.
   PubMed Web of Science ®Google Scholar
• Araujo LF, Mirza SS, Bos D, Niessen WJ, Barreto SM, van der Lugt A, et al. Association of coffee consumption with MRI markers and cognitive function: a population-based study. J Alzheimers Dis. 2016;53(2):451–61.
   PubMed Web of Science ®Google Scholar
• Haller S, Montandon ML, Rodriguez C, Herrmann FR, Giannakopoulos P. Impact of coffee, wine, and chocolate consumption on cognitive outcome and MRI parameters in old age. Nutrients 2018;10(10):1391.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Wolk A. The role of lifestyle factors and sleep duration for late-onset dementia: a cohort study. Journal of Alzheimer's Disease: Jad. 2018;66(2):579–86.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Orsini N. Coffee consumption and risk of dementia and Alzheimer's disease: A dose-response meta-analysis of prospective studies. Nutrients 2018;10(10):1501.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS. Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis. BMJ 2017;359:j5375.
   PubMedGoogle Scholar
• Pham K, Mulugeta A, Zhou A, O'Brien JT, Llewellyn DJ, Hyppönen E. High coffee consumption, brain volume and risk of dementia and stroke. Nutr Neurosci. 2021;24:1–12.
   PubMedGoogle Scholar
• Iranpour S, Saadati HM, Koohi F, Sabour S. Association between caffeine intake and cognitive function in adults; effect modification by sex: data from National Health and Nutrition Examination Survey (NHANES) 2013-2014. Clin Nutr. 2020;39(7):2158–68.
   PubMed Web of Science ®Google Scholar
• Mancini RS, Wang Y, Weaver DF. Phenylindanes in brewed coffee inhibit amyloid-beta and Tau aggregation. Front Neurosci. 2018;12:735.
   PubMed Web of Science ®Google Scholar
• Janitschke D, Lauer AA, Bachmann CM, Grimm HS, Hartmann T, Grimm MOW. Methylxanthines and neurodegenerative diseases: An update. Nutrients 2021;13(3):803.
   PubMed Web of Science ®Google Scholar
• Chen JQA, Scheltens P, Groot C, Ossenkoppele R. Associations between caffeine consumption, cognitive decline, and dementia: a systematic review. Journal of Alzheimer's Disease: Jad. 2020;78(4):1519–46.
   PubMed Web of Science ®Google Scholar
• Dong X, Li S, Sun J, Li Y, Zhang D. Association of coffee, decaffeinated coffee and caffeine intake from coffee with cognitive performance in older adults: National Health and Nutrition Examination Survey (NHANES) 2011-2014. Nutrients 2020;12(3):840.
   PubMed Web of Science ®Google Scholar
• Paz-Graniel I, Babio N, Becerra-Tomás N, Toledo E, Camacho-Barcia L, Corella D, et al. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population. European Journal of Nutrition. 2021;60(5):2381–96.
   PubMed Web of Science ®Google Scholar
• Matsushita N, Nakanishi Y, Watanabe Y, Kitamura K, Kabasawa K, Takahashi A, et al. Association of coffee, green tea, and caffeine with the risk of dementia in older Japanese people. J Am Geriatr Soc. 2021;69(12):3529–3544.
   PubMed Web of Science ®Google Scholar
• Vanderlee L, Reid JL, White CM, Acton RB, Kirkpatrick SI, Pao C-I, et al. Evaluation of a 24-hour caffeine intake assessment compared with urinary biomarkers of caffeine intake among young adults in Canada. J Acad Nutr Diet. 2018;118(12):2245–2253.e1.
   PubMed Web of Science ®Google Scholar
• Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018;70(2):384–411.
   PubMed Web of Science ®Google Scholar
• Petrovic D, Estoppey Younes S, Pruijm M, Ponte B, Ackermann D, Ehret G, et al. Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general population. Nutr Metab (Lond). 2016;13:81.
   PubMed Web of Science ®Google Scholar
• Rybak ME, Sternberg MR, Pao C-I, Ahluwalia N, Pfeiffer CM. Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake. J Nutr. 2015;145(4):766–74.
   PubMed Web of Science ®Google Scholar
• Peng S, Shen Y, Wang M, Zhang J. Serum and CSF metabolites in stroke-free patients are associated with vascular risk factors and cognitive performance. Front Aging Neurosci. 2020;12:193.
   PubMed Web of Science ®Google Scholar
• de Leeuw FA, van der Flier WM, Tijms BM, Scheltens P, Mendes VM, Manadas B, et al. Specific nutritional biomarker profiles in mild cognitive impairment and subjective cognitive decline are associated with clinical progression: the NUDAD project. J Am Med Dir Assoc. 2020;21(10):1513.e1–1513.e17.
   PubMed Web of Science ®Google Scholar
• Chen SP, Bhattacharya J, Pershing S. Association of vision loss with cognition in older adults. JAMA Ophthalmol. 2017;135(9):963–70.
   PubMed Web of Science ®Google Scholar
• Zhou J, Ma L, Zhao L, Sheng J, Xu Y, Chen J, et al. Association between the prognostic nutritional index and cognitive function Among older adults in the United States: a population-based study. J Alzheimers Dis. 2021;83(2):819–31.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jin X, Lutz MW, Ju S-Y, Liu K, Guo G, et al. Interaction between APOE ϵ4 and dietary protein intake on cognitive decline: a longitudinal cohort study. Clin Nutr. 2021;40(5):2716–25.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2009;169(2):236–48.
   PubMed Web of Science ®Google Scholar
• West RK, Ravona-Springer R, Livny A, Heymann A, Shahar D, Leroith D, et al. Age modulates the association of caffeine intake with cognition and with gray matter in elderly diabetics. J Gerontol A Biol Sci Med Sci. 2019;74(5):683–8.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Li G, Ren H, Chen W. Caffeine effect on cognitive function during a stroop task: fNIRS study. Neural Plast 2020;2020:8833134.
   PubMed Web of Science ®Google Scholar
• Baba Y, Inagaki S, Nakagawa S, Kobayashi M, Kaneko T, Takihara T. Effects of daily matcha and caffeine intake on Mild acute psychological stress-related cognitive function in middle-aged and older adults: a randomized placebo-controlled study. Nutrients 2021;13(5):1700.
   PubMed Web of Science ®Google Scholar
• Chu Y-F, Chang W-H, Black RM, Liu J-R, Sompol P, Chen Y, et al. Crude caffeine reduces memory impairment and amyloid β(1-42) levels in an Alzheimer's mouse model. Food Chem 2012;135(3):2095–102.
   PubMed Web of Science ®Google Scholar
• Dragicevic N, Delic V, Cao C, Copes N, Lin X, Mamcarz M, et al. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells. Neuropharmacology 2012;63(8):1368–79.
   PubMed Web of Science ®Google Scholar
• Crotty GF, Maciuca R, Macklin EA, Wang J, Montalban M, Davis SS, et al. Association of caffeine and related analytes with resistance to Parkinson disease among mutation carriers: a metabolomic study. Neurology. 2020;95(24):e3428–e37.
   PubMed Web of Science ®Google Scholar
• Fujimaki M, Saiki S, Li Y, Kaga N, Taka H, Hatano T, et al. Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease. Neurology. 2018;90(5):e404–e11.
   PubMed Web of Science ®Google Scholar
• Janitschke D, Lauer AA, Bachmann CM, Seyfried M, Grimm HS, Hartmann T, et al. Unique role of caffeine compared to other methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in regulation of AD relevant genes in neuroblastoma SH-SY5Y wild type cells. Int J Mol Sci. 2020;21(23):9015.
   PubMed Web of Science ®Google Scholar
• Londzin P, Zamora M, Kąkol B, Taborek A, Folwarczna J. Potential of caffeine in Alzheimer's disease-a review of experimental studies. Nutrients 2021;13(2):537.
   PubMed Web of Science ®Google Scholar
• Cappelletti S, Piacentino D, Daria P, Sani G, Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? Curr Neuropharmacol. 2015;13(1):71–88.
   PubMed Web of Science ®Google Scholar
• Han K, Jia N, Li J, Yang L, Min L-Q. Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1/APP double transgenic mouse model of Alzheimer's disease. Mol Med Rep. 2013;8(3):737–40.
   PubMed Web of Science ®Google Scholar
• Wu L, Sun D, He Y. Coffee intake and the incident risk of cognitive disorders: a dose-response meta-analysis of nine prospective cohort studies. Clin Nutr. 2017;36(3):730–6.
   PubMed Web of Science ®Google Scholar
• Tenkorang MA, Snyder B, Cunningham RL. Sex-related differences in oxidative stress and neurodegeneration. Steroids. 2018;133:21–7.
   PubMed Web of Science ®Google Scholar
• Jee HJ, Lee SG, Bormate KJ, Jung Y-S. Effect of caffeine consumption on the risk for neurological and psychiatric disorders: sex differences in human. Nutrients 2020;12(10):3080.
   PubMed Web of Science ®Google Scholar
• Temple JL, Ziegler AM. Gender differences in subjective and physiological responses to caffeine and the role of steroid hormones. J Caffeine Res. 2011;1(1):41–8.
   PubMedGoogle Scholar
• Mullins VA, Bresette W, Johnstone L, Hallmark B, Chilton FH. Genomics in personalized nutrition: can you “eat for your genes"? Nutrients 2020;12(10):3118.
   PubMed Web of Science ®Google Scholar